iopanoic acid has been researched along with Hyperthyroid in 21 studies
Iopanoic Acid: Radiopaque medium used as diagnostic aid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Telepaque [iopanoic acid (IA)] is believed to rapidly ameliorate hyperthyroidism; however, it may preclude subsequent 131I therapy, possibly delaying it for several months." | 9.11 | Effect of iopanoic acid on radioiodine therapy of hyperthyroidism: long-term outcome of a randomized controlled trial. ( Bal, CS; Chandra, P; Kumar, A, 2005) |
| "Amiodarone-induced thyrotoxicosis (AIT) may develop either in apparently normal glands (type II AIT) or in the presence of thyroid abnormalities (type I AIT)." | 9.10 | Preparation with iopanoic acid rapidly controls thyrotoxicosis in patients with amiodarone-induced thyrotoxicosis before thyroidectomy. ( Aghini-Lombardi, F; Bartalena, L; Berti, P; Bogazzi, F; Braverman, LE; Brogioni, S; Cosci, C; Martino, E; Materazzi, G; Miccoli, P; Pinchera, A, 2002) |
| "Iopanoic acid is an iodine containing oral cholecystographic agent that has been used to treat hyperthyroidism in humans and has recently been evaluated in an experimental model of feline hyperthyroidism." | 7.77 | Efficacy of iopanoic acid for treatment of spontaneous hyperthyroidism in cats. ( Gallagher, AE; Panciera, DL, 2011) |
| "Iopanoic acid (1 g/d) was used together with propylthiouracil (1200 mg/d) in the treatment of a patient with very severe hyperthyroidism and associated cardiac failure." | 7.67 | Iopanoic acid is of minimal benefit in the treatment of severe hyperthyroidism: conclusions from a case study. ( Hamblin, PS; Mohr, VS; Stockigt, JR; Topliss, DJ, 1985) |
| "iopanoic acid) potently inhibit the activation of T(4) to the more potent T(3)." | 5.32 | Treatment of hyperthyroidism associated with thyrotropin-secreting pituitary adenomas with iopanoic acid. ( Chopra, IJ; Cohan, P; Darwin, CH; Dhillon, KS; Iyer, KV; Kelly, DF, 2004) |
| "To investigate the effects of iopanoic acid (IA) and carbimazole on increased activity of the hypothalamic-pituitary-adrenal (HPA) axis in hyperthyroidism, we studied 14 women with hyperthyroidism caused by Graves' disease (n + 11) or toxic multinodular goitre (n + 3) before and after carbimazole or IA treatment." | 5.13 | Effects of different treatments for hyperthyroidism on the hypothalamic-pituitary-adrenal axis. ( Lizcano, F; Salvador, J, 2008) |
| "Telepaque [iopanoic acid (IA)] is believed to rapidly ameliorate hyperthyroidism; however, it may preclude subsequent 131I therapy, possibly delaying it for several months." | 5.11 | Effect of iopanoic acid on radioiodine therapy of hyperthyroidism: long-term outcome of a randomized controlled trial. ( Bal, CS; Chandra, P; Kumar, A, 2005) |
| "Amiodarone-induced thyrotoxicosis (AIT) may develop either in apparently normal glands (type II AIT) or in the presence of thyroid abnormalities (type I AIT)." | 5.10 | Preparation with iopanoic acid rapidly controls thyrotoxicosis in patients with amiodarone-induced thyrotoxicosis before thyroidectomy. ( Aghini-Lombardi, F; Bartalena, L; Berti, P; Bogazzi, F; Braverman, LE; Brogioni, S; Cosci, C; Martino, E; Materazzi, G; Miccoli, P; Pinchera, A, 2002) |
| "Iopanoic acid is an iodine containing oral cholecystographic agent that has been used to treat hyperthyroidism in humans and has recently been evaluated in an experimental model of feline hyperthyroidism." | 3.77 | Efficacy of iopanoic acid for treatment of spontaneous hyperthyroidism in cats. ( Gallagher, AE; Panciera, DL, 2011) |
| "The purpose of this study was to evaluate the safety and effect of iopanoic acid in 13 cats with hyperthyroidism induced by daily subcutaneous administration of 25microg/kg levothyroxine for a period of 42 days." | 3.75 | Effects and safety of iopanoic acid in cats administered levothyroxine. ( Gallagher, AE; Panciera, DL, 2009) |
| " We have now studied the effect of a decrease in serum T3 levels on the GH response to GHRP-6 (1 microg/kg) plus GHRH (100 microg) in 9 hyperthyroid patients before and after 15 days of treatment with iopanoic acid (3 g every 3 days) and propylthiouracil (600 mg/day)." | 3.72 | Acute decrease in circulating T3 levels enhances, but does not normalise, the GH response to GHRP-6 plus GHRH in thyrotoxicosis. ( Lengyel, AM; Nascif, SO; Ramos-Dias, JC; Senger, MH, 2003) |
| "We have evaluated an alternative method of preparation of hyperthyroid patients for surgery, using betamethasone, iopanoic acid and propranolol." | 3.68 | Rapid preoperative preparation in hyperthyroidism. ( Aguayo, J; Baeza, A; Barria, M; Pineda, G, 1991) |
| "Iopanoic acid (1 g/d) was used together with propylthiouracil (1200 mg/d) in the treatment of a patient with very severe hyperthyroidism and associated cardiac failure." | 3.67 | Iopanoic acid is of minimal benefit in the treatment of severe hyperthyroidism: conclusions from a case study. ( Hamblin, PS; Mohr, VS; Stockigt, JR; Topliss, DJ, 1985) |
| "Hyperthyroidism was controlled and symptoms improved markedly in each case without any evidence of subsequent relapse of thyroiditis after withdrawal of OCAs." | 2.71 | Use of oral cholecystography agents in the treatment of hyperthyroidism of subacute thyroiditis. ( Chopra, IJ; Martinez, DS, 2003) |
| "iopanoic acid) potently inhibit the activation of T(4) to the more potent T(3)." | 1.32 | Treatment of hyperthyroidism associated with thyrotropin-secreting pituitary adenomas with iopanoic acid. ( Chopra, IJ; Cohan, P; Darwin, CH; Dhillon, KS; Iyer, KV; Kelly, DF, 2004) |
| " Each patient received 25 microCi [125I]rT3, iv, in the high T4 state and on day 3 of each IA dosing regimen." | 1.28 | Does a hidden pool of reverse triiodothyronine (rT3) production contribute to total thyroxine (T4) disposal in high T4 states in man. ( Anderson, KP; LoPresti, JS; Nicoloff, JT, 1990) |
| "Dithiothreitol (DTT) was required for detectable metabolic reactions: 100 mM DTT was routinely used." | 1.26 | Phenolic and tyrosyl ring deiodination of iodothyronines in rat brain homogenates. ( Kaplan, MM; Yaskoski, KA, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (42.86) | 18.7374 |
| 1990's | 4 (19.05) | 18.2507 |
| 2000's | 7 (33.33) | 29.6817 |
| 2010's | 1 (4.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gallagher, AE | 2 |
| Panciera, DL | 2 |
| Bogazzi, F | 1 |
| Miccoli, P | 1 |
| Berti, P | 1 |
| Cosci, C | 1 |
| Brogioni, S | 1 |
| Aghini-Lombardi, F | 1 |
| Materazzi, G | 1 |
| Bartalena, L | 1 |
| Pinchera, A | 1 |
| Braverman, LE | 1 |
| Martino, E | 1 |
| Martinez, DS | 1 |
| Chopra, IJ | 2 |
| Nascif, SO | 1 |
| Senger, MH | 1 |
| Ramos-Dias, JC | 1 |
| Lengyel, AM | 1 |
| Dhillon, KS | 1 |
| Cohan, P | 1 |
| Kelly, DF | 1 |
| Darwin, CH | 1 |
| Iyer, KV | 1 |
| Bal, CS | 1 |
| Kumar, A | 1 |
| Chandra, P | 1 |
| Lizcano, F | 1 |
| Salvador, J | 1 |
| Chou, FF | 1 |
| Wang, CH | 1 |
| Chen, MF | 1 |
| Huang, BY | 1 |
| Chen, CW | 1 |
| Huang, MJ | 1 |
| Kaplan, MM | 1 |
| Yaskoski, KA | 1 |
| Baeza, A | 1 |
| Aguayo, J | 1 |
| Barria, M | 1 |
| Pineda, G | 1 |
| Kieffer, JD | 1 |
| Larsen, PR | 1 |
| Bal, C | 1 |
| Nair, N | 1 |
| LoPresti, JS | 1 |
| Anderson, KP | 1 |
| Nicoloff, JT | 1 |
| St Germain, DL | 1 |
| Hamblin, PS | 1 |
| Mohr, VS | 1 |
| Stockigt, JR | 1 |
| Topliss, DJ | 1 |
| Hayashi, K | 2 |
| West, CD | 2 |
| Chavré, VJ | 2 |
| Wolfe, M | 2 |
| Sparagana, M | 1 |
| Phillips, G | 1 |
| Kucera, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Multi-center, Open Label, Randomised Parallel- Group Study to Compare the Efficacy of Cholestyramine Plus Standard Treatment Versus Prednisolone Plus Standard Treatment Versus Standard Treatment Alone in Treatment of Overt Hyperthyroidism[NCT03303053] | Phase 3 | 135 participants (Anticipated) | Interventional | 2017-05-11 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 trials available for iopanoic acid and Hyperthyroid
| Article | Year |
|---|---|
Preparation with iopanoic acid rapidly controls thyrotoxicosis in patients with amiodarone-induced thyrotoxicosis before thyroidectomy.
Topics: Aged; Aged, 80 and over; Amiodarone; Contrast Media; Enzyme Inhibitors; Female; Humans; Hyperthyroid | 2002 |
Use of oral cholecystography agents in the treatment of hyperthyroidism of subacute thyroiditis.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Cholecystography; Contrast Media; Female; Humans; | 2003 |
Effect of iopanoic acid on radioiodine therapy of hyperthyroidism: long-term outcome of a randomized controlled trial.
Topics: Adult; Aged; Antithyroid Agents; Carbimazole; Female; Humans; Hyperthyroidism; Iodine Radioisotopes; | 2005 |
Effects of different treatments for hyperthyroidism on the hypothalamic-pituitary-adrenal axis.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Antithyroid Agents; Carbimazole; Corticotropin-Relea | 2008 |
The therapeutic efficacy of oral cholecystographic agent (iopanoic acid) in the management of hyperthyroidism.
Topics: Administration, Oral; Adult; Female; Humans; Hyperthyroidism; Iodine Radioisotopes; Iopanoic Acid; M | 1990 |
Serum thyroxine by competitive protein binding analysis: clinical, statistical and comparative evaluation.
Topics: Blood Chemical Analysis; Blood Proteins; Chemistry, Clinical; Chromatography, Ion Exchange; Clinical | 1969 |
15 other studies available for iopanoic acid and Hyperthyroid
| Article | Year |
|---|---|
Effects and safety of iopanoic acid in cats administered levothyroxine.
Topics: Analysis of Variance; Animals; Cat Diseases; Cats; Female; Hyperthyroidism; Iopanoic Acid; Random Al | 2009 |
Efficacy of iopanoic acid for treatment of spontaneous hyperthyroidism in cats.
Topics: Animals; Antithyroid Agents; Cat Diseases; Cats; Dose-Response Relationship, Drug; Female; Hyperthyr | 2011 |
Acute decrease in circulating T3 levels enhances, but does not normalise, the GH response to GHRP-6 plus GHRH in thyrotoxicosis.
Topics: Adolescent; Adult; Antithyroid Agents; Area Under Curve; Female; Fluorescent Antibody Technique; Gro | 2003 |
Treatment of hyperthyroidism associated with thyrotropin-secreting pituitary adenomas with iopanoic acid.
Topics: Adenoma; Adult; Female; Humans; Hyperthyroidism; Iopanoic Acid; Magnetic Resonance Imaging; Male; Pi | 2004 |
[Surgery of hyperthyroidism prepared with telepaque (author's transl)].
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Humans; Hyperthyroidism; Infant; Iodine; Iopanoi | 1980 |
Phenolic and tyrosyl ring deiodination of iodothyronines in rat brain homogenates.
Topics: Animals; Brain; Dithiothreitol; Hydrogen-Ion Concentration; Hyperthyroidism; Hypothyroidism; In Vitr | 1980 |
Rapid preoperative preparation in hyperthyroidism.
Topics: Adolescent; Adult; Betamethasone; Drug Administration Schedule; Female; Humans; Hyperthyroidism; Iop | 1991 |
Photoaffinity labeling of rat type I iodothyronine deiodinase.
Topics: Affinity Labels; Animals; Binding, Competitive; Diazonium Compounds; Hyperthyroidism; Hypothyroidism | 1991 |
Does a hidden pool of reverse triiodothyronine (rT3) production contribute to total thyroxine (T4) disposal in high T4 states in man.
Topics: Adult; Dose-Response Relationship, Drug; Humans; Hyperthyroidism; Injections, Intravenous; Iodide Pe | 1990 |
Dual mechanisms of regulation of type I iodothyronine 5'-deiodinase in the rat kidney, liver, and thyroid gland. Implications for the treatment of hyperthyroidism with radiographic contrast agents.
Topics: Animals; Carcinoma, Hepatocellular; Contrast Media; Hyperthyroidism; Iodide Peroxidase; Iopanoic Aci | 1988 |
Iopanoic acid is of minimal benefit in the treatment of severe hyperthyroidism: conclusions from a case study.
Topics: Cell Nucleus; Drug Therapy, Combination; Female; Humans; Hyperthyroidism; Iopanoic Acid; Middle Aged | 1985 |
[Effect of various iodine-containing compounds on thyroid function tests. 2. Protein-bound iodine].
Topics: Adult; Cholecystography; Contrast Media; Diatrizoate; Female; Humans; Hyperthyroidism; Hysterosalpin | 1972 |
A simple method for estimating serum thyroxine concentration in thyroid disease and iodine-treated patients.
Topics: Chemistry, Clinical; Contrast Media; Diatrizoate; Humans; Hyperthyroidism; Hypothyroidism; Iopanoic | 1966 |
[Effect of various iodine-containing compounds on thyroid function tests. 1. 24-hour 131 I uptake of the thyroid gland].
Topics: Adult; Cholecystography; Contrast Media; Diatrizoate; Female; Humans; Hyperthyroidism; Hysterosalpin | 1972 |
A serum thyroxine method: application in thyroid disease and iodine-treated patients.
Topics: Blood Chemical Analysis; Chromatography; Chromatography, Thin Layer; Contrast Media; Diatrizoate; Hu | 1965 |